Evidence map›Paper›PMID 39519801›Full record

ArticleMolecules (Basel, Switzerland)2024

A Study and In Vitro Evaluation of the Bioactive Compounds of Broad Bean Sprouts for the Treatment of Parkinson's Syndrome.

Danni Hu, Guanglei Qing, Xuecheng Liu, Jianming Cheng, Kewei Zhang, Lingyun He

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Danni HuCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Guanglei QingCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Xuecheng LiuCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Jianming ChengCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Kewei ZhangCollege of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Lingyun HeNanjing Core Tech Biomedical Co., Ltd., Nanjing 211100, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Levodopa (LD) is the first discovered and the most promising and effective medication for Parkinson's disease (PD). As the first identified natural source of LD,

Indexed as

Parkinson DiseasePlant ExtractsVicia fabaAnimalsAntioxidantsHumansPC12 CellsPhytochemicalsRatsSeedlingsAntioxidantsPhytochemicalsPlant Extractsbroad bean sproutscolumn chromatographynetwork pharmacologyneuroprotective effectsParkinson’s disease

Identifiers

PMID39519801
PMCPMC11547941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.